Strategic Leadership The recent appointment of a new President & CEO indicates Solesis is entering a new growth phase, presenting opportunities to explore their evolving strategic priorities and identify tailored solutions to support their expansion initiatives.

Expansion in Manufacturing With plans to build a new manufacturing facility in Costa Rica, Solesis is scaling its production capabilities, opening opportunities for suppliers, logistics partners, and collaborators in regional supply chain and facility management.

Innovation in Medical Textiles Solesis is actively developing engineered textiles for implantable medical devices across cardiovascular, orthopedic, and surgical applications, signaling a need for advanced textile solutions and partnerships to enhance product innovation.

Focus on Biomaterials Their ongoing development of polymer-based biomaterials for biopharma and medical devices suggests potential demand for specialized materials, R&D collaborations, or technology licensing opportunities.

Market Position and Growth With an estimated revenue of up to 25 million dollars and recent acquisitions like Polyzen, Solesis is focused on expanding its market share in the biomaterials and medical device sectors, indicating opportunities for targeted sales pitches in high-growth segments.